Nemark A I, Mazyrko A V, Astakhov Iu I
Ter Arkh. 1989;61(6):86-8.
As many as 142 patients with calculous pyelonephritis were examined for the system of hemostasis. It is shown that pyelonephritis is characterized by hypercoagulation shifts according to the echitox test, by the high content of fibrinogen and its degradation products, thrombinemia, a decrease of the antithrombin III level, and by high heparin resistance of plasma. At the same time there was a reduction of fibrinolysis. Thirty-six patients with the most pronounced disorders of hemostasis underwent multimodality treatment including plasmapheresis which favoured an improvement of the patients' status. The body temperature declined, the signs of intoxication disappeared, and the well-being improved. Hypercoagulation tended to disappearance, whereas the content of fibrinogen and its degradation products decreased. The level of antithrombin III rose and plasma resistance to heparin disappeared. At the same time the characteristics of the paracoagulation tests identifying thrombinemia remained unchanged. No noticeable changes in fibrinolysis were recorded. It is suggested that plasmapheresis should be widely used in multimodality treatment of pyelonephritis.
对多达142例结石性肾盂肾炎患者的止血系统进行了检查。结果表明,根据埃希托克斯试验,肾盂肾炎的特征是血液高凝状态改变、纤维蛋白原及其降解产物含量高、凝血酶血症、抗凝血酶III水平降低以及血浆肝素抵抗性高。与此同时,纤维蛋白溶解减少。36例止血障碍最明显的患者接受了包括血浆置换在内的多模式治疗,这有利于改善患者的状况。体温下降,中毒症状消失,身体状况改善。高凝状态趋于消失,而纤维蛋白原及其降解产物的含量降低。抗凝血酶III水平升高,血浆对肝素的抵抗消失。与此同时,识别凝血酶血症的副凝试验特征保持不变。纤维蛋白溶解未见明显变化。建议血浆置换应广泛应用于肾盂肾炎的多模式治疗。